Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29212840 | 1.00 | TSHR (0.65) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| Triethyl Phosphate SCHEMBL31533519 | 0.92 | TSHR (0.77) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL555003 | 0.87 | ALDH1A1 (0.50) | TSHRCYP3A4ALDH1A1 | |
| SCHEMBL5462392 | 0.86 | TSHR (0.59) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL30902591 | 0.85 | CYP3A4 (0.54) | TSHRCYP3A4ALDH1A1MEN1KMT2A | |
| SCHEMBL16187636 | 0.84 | TSHR (0.56) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL8962338 | 0.84 | TSHR (0.81) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL22288214 | 0.84 | ALDH1A1 (0.48) | TSHRCYP3A4ALDH1A1 | |
| Methacrylic Acid SCHEMBL28569654 | 0.83 | TSHR (0.45) | TSHRCYP3A4CA12CA1CA2 | |
| SCHEMBL6953430 | 0.82 | TSHR (0.54) | TSHRCYP3A4ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735979-A | Single-component anti-corrosion antirust water-based reactive primer and preparation method thereof | 河北比尔尼克新材料科技股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-109517470-B | Water-based ultrathin fireproof coating and preparation method thereof | 中建西部建设股份有限公司 | 2021-07-02 | — | — | CN | claimed |
| EP-2428235-B1 | Use of compounds hardened by means of polymerisation for producing biodegradable, biocompatible, networked polymers | UNIV WIEN TECH (AT) | 2014-06-04 | — | — | EP | claimed |
| CN-119735979-A | Single-component anti-corrosion antirust water-based reactive primer and preparation method thereof | 河北比尔尼克新材料科技股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-115403558-A | Aromatic heterocyclic compound with antitumor activity and preparation method and application thereof | 河南真实生物科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-109517470-B | Water-based ultrathin fireproof coating and preparation method thereof | 中建西部建设股份有限公司 | 2021-07-02 | — | — | CN | disclosed |
| CN-106146367-A | Allyl sulfenyl amino 1,4-benzoquinone compounds, its preparation and application | 北京大学 | 2016-11-23 | — | — | CN | disclosed |
| US-8501714-B2 | Inhibitors of Flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120156166-A1 | INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-7078406-B2 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) | 2006-07-18 | — | — | US | disclosed |
| US-20040248851-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | Life Technologies Corporation | 2004-12-09 | — | — | US | disclosed |
| US-6815445-B2 | FOR USE AS FLUORESCENCE DYES AND PROBES | Life Technologies Corporation | 2004-11-09 | — | — | US | disclosed |
| US-20030105111-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156166-A1 | INHIBITORS OF FLAVIVIRIDAE VIRUSES | HAVCR2, CYP2F1, CYP4F3 | TSHR 4286/4885CYP3A4 19/4885ALDH1A1 462/4885 |
| US-20040248851-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | DHFR, FPR1, CYP1A1 | TSHR 4569/4885CYP3A4 95/4885ALDH1A1 37/4885 |
| US-20030105111-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | DHFR, FPR1, CYP1A1 | TSHR 4569/4885CYP3A4 95/4885ALDH1A1 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.